Düsseldorf, 05 November 2024. The previous forecast of bet-at-home.com AG (hereinafter also referred to as the "BaH") assumed that bet-at-home.com AG Group will achieve in the financial year 2024 ...
Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, today announced that it expects the Swiss SIX exchange to ...
GENEVA (NOV. 4, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options ...
LEG subsidiary and Adler Real Estate GmbH (Adler) enter into share purchase agreement regarding 52.68% of the shares in Brack Capital Properties N.V. (BCP) Adler commits to tender additional 10.1% ...